KALA

KALA

USD

KALA BIO Inc. Common Stock

$0.751+0.011 (1.527%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.740

Hoch

$0.800

Tief

$0.740

Volumen

0.08M

Unternehmensfundamentaldaten

Marktkapitalisierung

5.3M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.11M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.74Aktuell $0.751Hoch $20.6

Ähnliche Nachrichten

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio with a Buy and raises the price target from $12 to $35.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35
Analyst Upgrades

Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio with a Outperform and raises the price target from $15 to $33.

Mehr anzeigen
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33
Analyst Upgrades

Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio with a Outperform rating and announces Price Target of $30.

Mehr anzeigen
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30
GlobeNewswire

KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director

ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for

Mehr anzeigen
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.